HomeTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Previous close
₹636.40
Day range
₹631.00 - ₹642.70
Year range
₹506.80 - ₹722.65
Market cap
33.93B INR
Avg Volume
75.79K
P/E ratio
47.40
Dividend yield
-
Primary exchange
NSE
Market news
MarketWatch
8 hours ago
Nvidia’s stock sees some gains melt — but an analyst glimpses big upside
ahead
2.48%
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 1.54B | 13.52% |
Operating expense | 603.60M | 67.39% |
Net income | 177.80M | 42.58% |
Net profit margin | 11.53 | 25.60% |
Earnings per share | 3.54 | 50.00% |
EBITDA | 325.02M | 43.91% |
Effective tax rate | 24.98% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.77B | 26.11% |
Total assets | 6.44B | 1.76% |
Total liabilities | 1.16B | 19.23% |
Total equity | 5.28B | — |
Shares outstanding | 50.23M | — |
Price to book | 6.07 | — |
Return on assets | — | — |
Return on capital | 9.39% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 177.80M | 42.58% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,645
